New Zealand markets closed

Intercept Pharmaceuticals, Inc. (ICPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.70+0.25 (+1.73%)
At close: 04:00PM EST
14.62 -0.08 (-0.54%)
Pre-market: 07:54AM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
379,842
363,468
312,690
252,002
179,804
Cost of revenue
3,285
3,100
5,322
4,212
2,519
Gross profit
376,557
360,368
307,368
247,790
177,285
Operating expenses
Research development
189,034
185,272
191,485
242,799
207,301
Selling general and administrative
221,613
230,855
332,493
317,418
255,474
Total operating expenses
410,647
416,127
523,978
560,217
462,775
Operating income or loss
-34,090
-55,759
-216,610
-312,427
-285,490
Interest expense
31,099
51,875
48,054
41,144
30,523
Total other income/expenses net
-89,480
18,752
-10,216
8,890
6,771
Income before tax
-157,465
-91,426
-274,880
-344,681
-309,242
Income from continuing operations
-157,465
-91,426
-274,880
-344,681
-309,242
Net income
206,361
-91,426
-274,880
-344,681
-309,242
Net income available to common shareholders
206,361
-91,426
-274,880
-344,681
-309,242
Basic EPS
-
-2.87
-8.34
-10.89
-10.86
Diluted EPS
-
-2.87
-8.34
-10.89
-10.86
Basic average shares
-
31,894
32,970
31,654
28,464
Diluted average shares
-
31,894
32,970
31,654
28,464
EBITDA
-
-36,573
-223,708
-299,874
-274,137